About this trial
The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and/or indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.
Eligibility criteria
Qualifiers
Diagnosed with cystic fibrosis
Diagnosed with exocrine pancreatic insufficiency
18 years old or older
Currently on modulator
Disqualifiers
Non-English-speaking participants
Acute health crisis
Persistent elevation of liver enzymes >6 months (E2) (ALT >80 U/L)
History of liver abnormalities
Trial design
Treatments tested in this trial
- Common form supplementation
- Uncommon nutrient supplementation